- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05259163
LFR-260 vs Traditional Phoropter in Visual Acuity Testing
An Evaluation of the LFR-260 Against a Traditional Phoropter in Visual Acuity Testing
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01608
- MCPHS
-
-
New York
-
Oyster Bay, New York, United States, 11771
- Gold Coast Optometric Vision
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The participant or legal guardian is willing and able to understand, sign and date the Ethics committee approved study specific Informed Consent Form.
- The participant is a male or female between the ages of 12 and 65 (inclusive).
- The participant has no more than mild to moderate far-sightedness, near-sightedness, astigmatism or anisometropia.
- The participant is free of ocular and systemic abnormalities that might affect visual functions.
Exclusion Criteria:
- The participant has diabetes mellitus (Type 1 or 2).
- The participant has an autoimmune condition.
- The participant is pregnant (self-reported).
- The participant has an active corneal or conjunctival infection.
- The participant has an active corneal, conjunctival, or intraocular inflammation (i.e. - uveitis).
- The participant has diabetic retinopathy.
- The participant has glaucoma or ocular hypertension.
- The participant has macular degeneration.
- The participant has had a previous ocular surgery.
- The participant has ocular and systemic diseases or abnormalities that might affect visual functions.
- The participant has a history of amblyopia, strabismus, or any other binocular vision abnormality.
- The participant has a history of AMD (age macular degeneration).
- The participant is a prisoner, a transient or has been treated for alcohol and/or drug abuse in an inpatient substance abuse program within 6 months prior to proposed study enrolment.
- The participant will not be able to complete questionnaires.
- The participant is currently in an investigational study for a similar purpose.
- The participant, in the judgment of the Investigator, may be inappropriate for the intended study procedures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1: LFR-260 first, then traditional phoropter
The LFR-260 was administered first in this group, followed by the traditional phoropter.
The LFR-260 is a portable digital refractor which allows for determination of refractive error as well as for fully remote refractions during eye exams.
The traditional phoropter is intended to be used for distance vision testing in any environment.
|
Portable unit to evaluate visual refractive state of the patient
Standard unit for evaluating visual refractive state of the patient
|
|
Active Comparator: Group II: Traditional Phoropter first, then LFR-260
The traditional phoropter was administered first in this group, followed by the traditional phoropter.
The traditional phoropter is intended to be used for distance vision testing in any environment.
The LFR-260 is a portable digital refractor which allows for determination of refractive error as well as for fully remote refractions during eye exams.
|
Portable unit to evaluate visual refractive state of the patient
Standard unit for evaluating visual refractive state of the patient
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effectiveness of LFR260 on Visual Acuity Test
Time Frame: Day 0
|
Agreement of LFR-260 (investigational device) to traditional phoropter (comparator device) when applied in visual acuity test (eye chart test) in subjects undergoing a full routine eye examination.
Agreement will be determined by demonstrating that the LFR-260 is within 0.5D (+/-) in measuring sphere and cylinder results and within 10 degrees for axis results among subjects with low astigmatism and within 5 degrees among subjects with moderate to high astigmatism from the traditional phoropter.
|
Day 0
|
|
Precision of LFR260 in Repeated Testing
Time Frame: Day 0
|
Precision testing will also be conducted to confirm repeatability and reproducibility of the LFR-260.
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Satisfaction Survey
Time Frame: Day 0
|
4-question survey (1=worst; 5=best) given to patients to determine satisfaction with LFR-260 device Quad view. Q1: Was the LFR-260 device Quad view comfortable to use for your eye exam? (1=very uncomfortable - 5=very comfortable) Q2: Did the LFR-260 Quad view feel the same as the traditional phoropter when taking your eye exam? (1=LFR-260 definitely more uncomfortable - 5=LFR-260 definitely more comfortable) Q3: Did you prefer to read the eye chart using the LFR-260 device Quad view or traditional phoropter? (1=definitely prefer phoropter - 5=definitely prefer LFR-260) Q4: If taking an eye exam in the future, would you prefer your doctor use the LFR-260 Quad view or traditional phoropter? (1=definitely prefer phoropter - 5=definitely prefer LFR-260) |
Day 0
|
|
Provider Satisfaction Survey
Time Frame: Day 0
|
4-question survey (1=worst; 5=best) given to eye care provider to determine satisfaction with LFR-260 related to usability, convenience. Q1: LFR-260 device performed as expected according to the Instructions for Use (IFU)? (1=definitely did not - 5=definitely) Q2: LFR-260 device was easy to use? (1=very difficult to use - 5=very easy to use) Q3: LFR-260 device was intuitive to operate? (1=definitely counterintuitive - 5=very intuitive) Q4: LFR-260 was more or less convenient to use than the phoropter? (1=definitely less convenient- 5=definitely more convenient) |
Day 0
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LFR-260-2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
London Vision ClinicOptana GmbHActive, not recruitingCorneal AstigmatismUnited Kingdom
-
Eye Hospital Pristina KosovoActive, not recruiting
-
Yonsei UniversityUnknownMyopic AstigmatismKorea, Republic of
-
Abbott Medical OpticsCompletedRefractive AstigmatismAustria
-
Ziemer Ophthalmic Systems AGTigermed Consulting Co., LtdRecruitingMyopic AstigmatismChina
-
Bausch & Lomb IncorporatedCompleted
-
CooperVision, Inc.CompletedAstigmatism BilateralCanada
-
University Clinic FrankfurtCompleted